AGI-5198 - CAS 1355326-35-0
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
AGI-5198
Catalog Number:
1355326-35-0
Synonyms:
IDH-C35
CAS Number:
1355326-35-0
Description:
AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.
Molecular Weight:
462.56
Molecular Formula:
C27H31FN4O2
COA:
Inquire
MSDS:
Inquire
Targets:
Isocitrate Dehydrogenase (IDH)
Chemical Structure
CAS 1355326-35-0 AGI-5198

Related Isocitrate Dehydrogenase (IDH) Products


Enasidenib (AG-221)
(CAS: 1446502-11-9)

Enasidenib, aslo known as AG-221 and CC-90007, is a potent and selective IDH2 inhibitor with potential anticancer activity (IDH2 = Isocitrate dehydrogenase 2).

Mutant IDH1-IN-1
(CAS: 1355326-21-4)

Mutant IDH1-IN-1, a mutant IDH1 R132H inhibitor, could be used in some biological studies.

CAS 1432660-47-3 AGI-6780

AGI-6780
(CAS: 1432660-47-3)

SCHEMBL14831541
(CAS: 1429180-08-4)

SCHEMBL14831541, also called as Mutant IDH1 inhibitor, is an inhibitor of mutant IDH1 which is key enzymes found in cellular metabolism.

CAS 1355326-35-0 AGI-5198

AGI-5198
(CAS: 1355326-35-0)

AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.

Mutant IDH1-IN-2
(CAS: 1429176-69-1)

Mutant IDH1-IN-2, aslo called as SCHEMBL14831158, is an inhibitor of mutant IDH protein. It is developed for the treatment of diseases associated with such muta...

GSK321
(CAS: 1816331-63-1)

GSK321 is a highly potent, selective inhibitor of mutant IDH1 enzymes, with IC50= 4.6 nM against R132H, 3.8 nM against R132C and 2.9 nM against R132G. GSK321 st...

Ivosidenib
(CAS: 1448347-49-6)

Ivosidenib, also called AG-120, is an oral inhibitor that specifically inhibits a mutated form of IDH1 in the cytoplasm.